The pill makes good company on those days or nights when deadlines loom. Drowsiness and distractions evaporate. Focus sharpens. Attention span stretches. A boring text takes on the gleam of a riveting page-turner.
This is from students who, without a prescription, have popped Adderall or Ritalin, or another medication used to treat Attention Deficit Hyperactivity Disorder.
One fourth-year Engineering student, who requested anonymity, said he first took a friend's Adderall February of his first year, just when the work load picked up and everything was due at the same time.
He asked his friend a couple questions
Read More
U.Va. Health’s Earn While You Learn program graduates its first nursing class
By Vrinda Vashisht | 2 days agoSixteen employees graduated this spring as the inaugural cohort for the program’s nursing track.
U.Va. Health expands AI use across patient care, research and education
By Michael Racz | August 2, 2026According to Eric Swensen, U.Va. Heath’s public information officer, U.Va. Health has begun utilizing AI tools in “carefully defined, low-risk ways” across the system in three distinct areas.
U.Va. researchers develop new approach to treating brain cancer, human trials are still years away
By Vrinda Vashisht | August 2, 2026This experimental treatment approach has been tested in mice, and U.Va. researchers say that human clinical trials are at least a few years away.
